PRCT FY 2024 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$224M+64.8% YoY

Gross Profit

$137M61.1% margin

Operating Income

-$97M-43.0% margin

Net Income

-$91M-40.7% margin

EPS (Diluted)

$-1.75

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$104M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$534M

Total Liabilities

$132M

Stockholders' Equity

$402M

Cash & Equivalents

$334M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$224M	$136M	+64.8%
Gross Profit	$137M	$71M	+93.0%
Operating Income	-$97M	-$109M	+11.5%
Net Income	-$91M	-$106M	+13.7%